Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3970867
Max Phase: Preclinical
Molecular Formula: C62H111N11O10S2
Molecular Weight: 1234.77
Molecule Type: Small molecule
Associated Items:
ID: ALA3970867
Max Phase: Preclinical
Molecular Formula: C62H111N11O10S2
Molecular Weight: 1234.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=S)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=S)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
Standard InChI: InChI=1S/C62H111N11O10S2/c1-25-27-28-40(15)52(75)51-54(77)65-43(26-2)58(79)67(18)33-48(74)68(19)45(30-35(5)6)56(85)66-49(38(11)12)61(82)69(20)44(29-34(3)4)53(76)63-41(16)55(84)64-42(17)57(78)70(21)46(31-36(7)8)59(80)71(22)47(32-37(9)10)60(81)72(23)50(39(13)14)62(83)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,76)(H,64,84)(H,65,77)(H,66,85)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1
Standard InChI Key: WXHOPLWYCKWXJL-CGLBZJNRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1234.77 | Molecular Weight (Monoisotopic): 1233.7957 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lin W, Erdmann F, Quintero A, Fischer G, Zhang Y.. (2016) Thioxylated cyclosporin A for studying protein-drug interactions., 26 (23): [PMID:27815116] [10.1016/j.bmcl.2016.10.050] |
Source(1):